198 related articles for article (PubMed ID: 9288970)
1. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Rüth FX; Maskos K; Betz M; Bergner A; Huber R; Suzuki K; Yoshida N; Nagase H; Brew K; Bourenkov GP; Bartunik H; Bode W
Nature; 1997 Sep; 389(6646):77-81. PubMed ID: 9288970
[TBL] [Abstract][Full Text] [Related]
2. Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.
Devel L; Garcia S; Czarny B; Beau F; LaJeunesse E; Vera L; Georgiadis D; Stura E; Dive V
J Biol Chem; 2010 Nov; 285(46):35900-9. PubMed ID: 20817735
[TBL] [Abstract][Full Text] [Related]
3. Structural properties of matrix metalloproteinases.
Bode W; Fernandez-Catalan C; Tschesche H; Grams F; Nagase H; Maskos K
Cell Mol Life Sci; 1999 Apr; 55(4):639-52. PubMed ID: 10357232
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.
Yan YL; Miller MT; Cao Y; Cohen SM
Bioorg Med Chem Lett; 2009 Apr; 19(7):1970-6. PubMed ID: 19261472
[TBL] [Abstract][Full Text] [Related]
5. Selectivity Conversion of Protease Inhibitory Antibodies.
Lopez T; Ramirez A; Benitez C; Mustafa Z; Pham H; Sanchez R; Ge X
Antib Ther; 2018 Sep; 1(2):55-63. PubMed ID: 30406213
[No Abstract] [Full Text] [Related]
6. TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity.
Langguth M; Maranou E; Koskela SA; Elenius O; Kallionpää RE; Birkman EM; Pulkkinen OI; Sundvall M; Salmi M; Figueiredo CR
Genes Immun; 2024 May; ():. PubMed ID: 38777826
[TBL] [Abstract][Full Text] [Related]
7. Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and
Talari NK; Mattam U; Kaminska D; Sotomayor-Rodriguez I; Rahman AP; Péterfy M; Pajukanta P; Pihlajamäki J; Chella Krishnan K
iScience; 2024 May; 27(5):109709. PubMed ID: 38689636
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Experimental and Calculated Inhibition Constants of Protease Inhibitor Complexes.
Goettig P; Chen X; Harris JM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397107
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Inducible Factor and Oxidative Stress in Tendon Degeneration: A Molecular Perspective.
Shahid H; Morya VK; Oh JU; Kim JH; Noh KC
Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38247510
[TBL] [Abstract][Full Text] [Related]
10. Tracing the evolution of tissue inhibitor of metalloproteinases in Metazoa with the
Ma CY; Chen Y; Zhan X; Dong YW
iScience; 2024 Jan; 27(1):108579. PubMed ID: 38161420
[TBL] [Abstract][Full Text] [Related]
11. Timp1 Deletion Induces Anxiety-like Behavior in Mice.
Wang X; Zheng W; Zhu Z; Xing B; Yan W; Zhu K; Xiao L; Yang C; Wei M; Yang L; Jin ZB; Bi X; Zhang C
Neurosci Bull; 2023 Dec; ():. PubMed ID: 38113013
[TBL] [Abstract][Full Text] [Related]
12. Structure and computation-guided yeast surface display for the evolution of TIMP-based matrix metalloproteinase inhibitors.
Shoari A; Khalili-Tanha G; Coban MA; Radisky ES
Front Mol Biosci; 2023; 10():1321956. PubMed ID: 38074088
[TBL] [Abstract][Full Text] [Related]
13. Human TIMP1 Is a Growth Factor That Improves Oocyte Developmental Competence.
Manríquez-Treviño Y; Sánchez-Ramírez B; Grado-Ahuir JA; Castro-Valenzuela B; González-Horta C; Burrola-Barraza ME
BioTech (Basel); 2023 Oct; 12(4):. PubMed ID: 37873882
[TBL] [Abstract][Full Text] [Related]
14. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
Hosseini A; Kumar S; Hedin K; Raeeszadeh-Sarmazdeh M
Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423
[TBL] [Abstract][Full Text] [Related]
15. Non-Canonical Amino Acids in Analyses of Protease Structure and Function.
Goettig P; Koch NG; Budisa N
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762340
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 Protects Tight Junctions of Brain Endothelial Cells From MMP-Mediated Degradation.
Ahmadighadykolaei H; Lambert JA; Raeeszadeh-Sarmazdeh M
Pharm Res; 2023 Sep; 40(9):2121-2131. PubMed ID: 37700105
[TBL] [Abstract][Full Text] [Related]
17. Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity.
Kalló G; Bertalan PM; Márton I; Kiss C; Csősz É
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686462
[TBL] [Abstract][Full Text] [Related]
18. The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2: Emerging Roles in Tissue Homeostasis and Cancer Progression.
Stetler-Stevenson WG
Am J Pathol; 2023 Oct; 193(10):1336-1352. PubMed ID: 37572947
[TBL] [Abstract][Full Text] [Related]
19. NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action.
Bozin TN; Berdyshev IM; Chukhontseva KN; Karaseva MA; Konarev PV; Varizhuk AM; Lesovoy DM; Arseniev AS; Kostrov SV; Bocharov EV; Demidyuk IV
J Biol Chem; 2023 Apr; 299(4):104585. PubMed ID: 36889586
[TBL] [Abstract][Full Text] [Related]
20. A unique network of attack, defence and competence on the outer membrane of the periodontitis pathogen
Książek M; Goulas T; Mizgalska D; Rodríguez-Banqueri A; Eckhard U; Veillard F; Waligórska I; Benedyk-Machaczka M; Sochaj-Gregorczyk AM; Madej M; Thøgersen IB; Enghild JJ; Cuppari A; Arolas JL; de Diego I; López-Pelegrín M; Garcia-Ferrer I; Guevara T; Dive V; Zani ML; Moreau T; Potempa J; Gomis-Rüth FX
Chem Sci; 2023 Jan; 14(4):869-888. PubMed ID: 36755705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
